Literature DB >> 16392797

Engineering cyclic tetrapeptides containing chimeric amino acids as preferred reverse-turn scaffolds.

Ye Che1, Garland R Marshall.   

Abstract

Four residues making almost a complete 180 degrees turn in the direction of the peptide chain define a reverse turn, a common motif and recognition site in proteins. Cyclization between residues i and i + 3 and incorporation of heterochiral dipeptides (such as d-Pro-l-Pro) in the i + 1 and i + 2 positions are used to constrain a peptide to a reverse-turn conformation. A combined approach, cyclic tetrapeptides (CTPs) based on heterochiral dipeptides of chimeric amino acids, is evaluated as minimalist scaffolds for reverse-turn conformations. Cyclo-(d-Pro-l-Pro-d-Pro-l-Pro) has been studied with density functional theory (DFT) calculations and molecular dynamics simulations. The all-trans amide conformer was the most stable in vacuo, while the cis-trans-cis-trans (ctct) or trans-cis-trans-cis (tctc) amide conformer was more favored in water due to its large dipole moment. Different conformations could be selectively stabilized by different substitutions on the proline rings. Due to the small 12-membered ring and exocyclic constraints, conformational interconversions could only occur at high temperature. The presence of seven hydrogens on each ring that could be functionalized offers an overwhelming diversity to design molecules to probe receptors. The spatial relationships of C(alpha)-C(beta) vectors of reverse turns in proteins were subjected to principal component analysis for determination of the relative orientation of the C(alpha)-C(beta) vectors. Most reverse-turn structures could be mimicked effectively with a subset of CTP scaffolds with an root-mean-square displacement (RMSD) of approximately 0.5 A. Structural diversity of CTP scaffolds could be enhanced by the incorporation of proline analogues, such as azaproline (azPro) or pipecolic (Pip), azapipecolic (azPip), nipecotic (Nip), and isonipecotic (Inp) acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392797     DOI: 10.1021/jm0507072

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

Review 2.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

3.  Synthesis of endolides A and B: naturally occurring N-methylated cyclic tetrapeptides.

Authors:  Emma K Davison; Alan J Cameron; Paul W R Harris; Margaret A Brimble
Journal:  Medchemcomm       Date:  2019-03-05       Impact factor: 3.597

4.  Solid-phase synthesis, cyclization, and site-specific functionalization of aziridine-containing tetrapeptides.

Authors:  Benjamin K W Chung; Christopher J White; Andrei K Yudin
Journal:  Nat Protoc       Date:  2017-05-24       Impact factor: 13.491

5.  Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors.

Authors:  Liv Johannessen; Jarrett Remsberg; Vadim Gaponenko; Kristie M Adams; Joseph J Barchi; Sergey G Tarasov; Sheng Jiang; Nadya I Tarasova
Journal:  Chembiochem       Date:  2011-03-01       Impact factor: 3.164

6.  Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.

Authors:  W Seth Horne; Christian A Olsen; John M Beierle; Ana Montero; M Reza Ghadiri
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  A virtual library of constrained cyclic tetrapeptides that mimics all four side-chain orientations for over half the reverse turns in the protein data bank.

Authors:  Sage Arbor; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2008-09-17       Impact factor: 3.686

Review 8.  Synthesis and Biomedical Potential of Azapeptide Modulators of the Cluster of Differentiation 36 Receptor (CD36).

Authors:  Caroline Proulx; Jinqiang Zhang; David Sabatino; Sylvain Chemtob; Huy Ong; William D Lubell
Journal:  Biomedicines       Date:  2020-07-23

9.  Exploring the Energy Landscapes of Cyclic Tetrapeptides with Discrete Path Sampling.

Authors:  Mark T Oakley; Roy L Johnston
Journal:  J Chem Theory Comput       Date:  2012-11-05       Impact factor: 6.006

10.  The reactivity and conformational control of cyclic tetrapeptides derived from aziridine-containing amino acids.

Authors:  Benjamin K W Chung; Christopher J White; Conor C G Scully; Andrei K Yudin
Journal:  Chem Sci       Date:  2016-06-30       Impact factor: 9.825

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.